About this trial
This is a prospective study that aims to develop clinical calculators that will report on the underlying rate of aortic valve calcification. To do so, baseline 18FNaF PET/CT will be obtained to measure AS disease activity and the rate of active microcalcification. Using these data, multi-omics prediction models and calculator tools will be developed to provide an index of ongoing disease activity (active calcification). Follow-up imaging (both echo and CT) will be performed one year after baseline imaging to assess progression. We will test the hypothesis that baseline disease activity (as reported by the predictor models and calculators) is associated with the rate of annualized AS progression in two cohorts (the same cohort using subsequent imaging, as well as the Population Study's cohorts).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Males and females
aged 18 years or older
mild to moderate calcific Aortic Stenosis (as defined by standard echocardiographic criteria)
Disqualifiers
Bicuspid Aortic Stenosis
pregnancy
cognitive disabilities that impair the ability to comply with instructions or provide informed consent
any other medical condition that may undermine participation
Trial population
100 subjects with mild or moderate aortic stenosis
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
rate of AS progression
change of echo- and CT-derived AS measures
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: